Opko Health(FRA) XCY

Market Cap€910.52M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€1.22

-0.81%

-0.01Today

Opko Health Financials at a Glance

Market Cap

€910.52M

Revenue (TTM)

€504.17

Net Income (TTM)

-€62.46

EPS (TTM)

-€0.08

P/E Ratio

-14.75

Dividend

€0.00

Beta (Volatility)

0.24 (Low)

Dividend

€0.00

Beta (Volatility)

0.24 (Low)

Price

€1.22

Volume

Open

€1.25

Price

€1.22

Volume

Open

€1.25

Previous Close

€1.22

Daily Range

€1.22 - €1.25

52-Week Range

€0.90 - €1.49

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.24 (Low)

Price

€1.22

Volume

Open

€1.25

Previous Close

€1.22

Daily Range

€1.22 - €1.25

52-Week Range

€0.90 - €1.49

Estimated Earnings Date

N/A

XCY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Opko Health

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,275

CEO

Phillip Frost, MD

Website

www.opko.com

XCY Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-5.84%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-6.78%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€910.52M

Shares Outstanding

746.33M

Volume

Avg. Volume

77.273

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Opko Health Performance Analysis

Opko Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 955,490,524	-36.4%
2023	2023-12-31	EUR 798,707,370	-16.4%
2024	2024-12-31	EUR 659,284,547	-17.5%
2025	2025-12-31	EUR 537,737,778	-18.4%

Opko Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.43	1005.9%
2023	2023-12-31	EUR -0.23	-46.5%
2024	2024-12-31	EUR -0.07	-69.5%
2025	2025-12-31	EUR -0.27	275.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€140.69

+1.0%

Gross Profit

€52.50

+2.0%

Gross Margin

37.32%

+2.0%

Market Cap

€910.52M

N/A

Market Cap/Employee

€0.43

N/A

Employees

2,275

N/A

Net Income

-€7.24

+0.1%

EBITDA

-€2.26

+0.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€611.25

+7.5%

Total Debt

€348.19

+1.0%

Accounts Receivable

€71.62

+0.8%

Inventory

€54.10

+1.0%

Long Term Debt

€328.11

+1.0%

Short Term Debt

€20.08

+0.9%

Return on Assets

-3.81%

+0.4%

Return on Invested Capital

-9.52%

N/A

Free Cash Flow

-€40.11

+0.5%

Operating Cash Flow

-€37.52

+0.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About XCY

What is the current price of Opko Health?

Opko Health is trading at €1.22 per share.

What is the 52-week range for Opko Health?

Over the past 52 weeks, Opko Health has traded between €0.90 and €1.49.

How much debt does Opko Health have?

As of the most recent reporting period, Opko Health reported total debt of €348.19M.

How much cash does Opko Health have on hand?

Opko Health reported €263.06M in cash and cash equivalents in its most recent financial results.

What is Opko Health’s dividend yield?

Opko Health does not currently have a dividend yield.

Opko Health(FRA) XCY

Opko Health Financials at a Glance

XCY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Opko Health

XCY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Opko Health Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XCY

What is the current price of Opko Health?

What is the 52-week range for Opko Health?

How much debt does Opko Health have?

How much cash does Opko Health have on hand?

What is Opko Health’s dividend yield?

Premium Investing Services